Clinical N3 is an independent risk factor of recurrence for breast cancer patients achieving pathological complete response and near-pathological complete response after neoadjuvant chemotherapy

BACKGROUND: Although achieving pathological complete response (pCR) and near-pathological complete response (near-pCR) after neoadjuvant chemotherapy (NAC) in breast cancer predicts a better outcome, some patients still experience recurrence. The aim of our study was to investigate the predictive fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xiaoyan, Xiu, Meng, Li, Qing, Wang, Jiayu, Fan, Ying, Luo, Yang, Cai, Ruigang, Li, Qiao, Chen, Shanshan, Yuan, Peng, Ma, Fei, Xu, Binghe, Zhang, Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582118/
https://www.ncbi.nlm.nih.gov/pubmed/36276123
http://dx.doi.org/10.3389/fonc.2022.1019925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582118/
https://www.ncbi.nlm.nih.gov/pubmed/36276123
http://dx.doi.org/10.3389/fonc.2022.1019925

Ejemplares similares